Document Detail

Effect of vaginal pH on efficacy of the controlled-release dinoprostone vaginal insert for cervical ripening/labor induction.
MedLine Citation:
PMID:  12854926     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate whether vaginal pH alters the efficacy of the controlled-release dinoprostone vaginal insert (Cervidil) for cervical ripening/labor induction. METHODS: Thirty-four women with an unfavorable cervix undergoing labor induction were enrolled in this prospective, double-blind investigation. Vaginal pH and Bishop score assessments were made by an independent examiner. All women received preinduction with the dinoprostone vaginal insert 10 mg intravaginally for 12 h. Twelve hours later, oxytocin induction initiated according to the standardized protocol and outcome data were collected. RESULTS: Mean (+/- SD) initial vaginal pH was 4.9 +/- 0.5 for the study cohort. No significant differences were noted between women with a high vaginal pH (> 4.5, n = 18) and those with a low vaginal pH (< or = 4.5, n = 16) with respect to maternal age, parity, gestational age, or initial Bishop score. Similarly, Bishop score change over the preinduction interval (3.2 vs. 3.3), time to active labor (28.6 vs. 24.6 h) and time to delivery (33.7 vs. 31.4 h) were not significantly different between the low and the high pH groups, respectively. Linear regression analysis revealed no significant association between vaginal pH and Bishop score change during the preinduction interval, time to active labor, time to complete dilatation, or time to delivery. CONCLUSION: Vaginal pH does not appear to influence the efficacy of the controlled-released dinoprostone vaginal insert for cervical ripening/labor induction.
P S Ramsey; P L Ogburn; D Y Harris; R H Heise; C S DiMarco; K D Ramin
Related Documents :
1986626 - Successful antepartum treatment of listeriosis.
9323396 - Home uterine activity monitoring in the prevention of very low birth weight.
7485336 - Incidence of adverse cardiopulmonary effects with low-dose continuous terbutaline infus...
9160976 - Maternal stress, hpa activity, and fetal/infant outcome.
2303846 - "size" and "shape" variables in the presence of covariates: an application to the sudde...
2868086 - Effect of bethanechol and metoclopramide on upper gastrointestinal motility in the kitten.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  13     ISSN:  1476-7058     ISO Abbreviation:  J. Matern. Fetal. Neonatal. Med.     Publication Date:  2003 Apr 
Date Detail:
Created Date:  2003-07-11     Completed Date:  2003-07-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  250-3     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35333-7333, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Intravaginal
Delayed-Action Preparations
Dinoprostone / administration & dosage*
Double-Blind Method
Gestational Age
Hydrogen-Ion Concentration
Labor, Induced / methods*
Linear Models
Maternal Age
Oxytocics / administration & dosage*
Oxytocin / administration & dosage
Prospective Studies
Vagina / chemistry*
Reg. No./Substance:
0/Delayed-Action Preparations; 0/Oxytocics; 363-24-6/Dinoprostone; 50-56-6/Oxytocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intrauterine transfusion for rhesus alloimmunization elevates fetal beta2-microglobulin levels.
Next Document:  Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor indu...